134 related articles for article (PubMed ID: 17944582)
1. [Effects of mycophenolate mofetil in ischemic acute renal failure in rats].
Chávez-Velásquez M; Pons H; Medina M; Quiroz Y; Parra G; Herrera J
Nefrologia; 2007; 27(4):448-58. PubMed ID: 17944582
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil attenuates renal ischemia/reperfusion injury.
Ventura CG; Coimbra TM; de Campos SB; de Castro I; Yu L; Seguro AC
J Am Soc Nephrol; 2002 Oct; 13(10):2524-33. PubMed ID: 12239241
[TBL] [Abstract][Full Text] [Related]
3. Effect of immunosuppression on damage, leukocyte infiltration, and regeneration after severe warm ischemia/reperfusion renal injury.
Ysebaert DK; De Greef KE; Vercauteren SR; Verhulst A; Kockx M; Verpooten GA; De Broe ME
Kidney Int; 2003 Sep; 64(3):864-73. PubMed ID: 12911536
[TBL] [Abstract][Full Text] [Related]
4. Effect of mycophenolate mofetil on rat kidney grafts with prolonged cold preservation.
Fuller TF; Hoff U; Rose F; Linde Y; Freise CE; Dragun D; Feng S
Kidney Int; 2006 Aug; 70(3):570-7. PubMed ID: 16788694
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats.
Romero F; Rodríguez-Iturbe B; Parra G; González L; Herrera-Acosta J; Tapia E
Kidney Int; 1999 Mar; 55(3):945-55. PubMed ID: 10027931
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil ameliorates accelerated progressive nephropathy in rat.
Bloudícková S; Rajnoch J; Lodererová A; Honsová E; Viklický O
Kidney Blood Press Res; 2006; 29(1):60-6. PubMed ID: 16645304
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil inhibits macrophage infiltration and kidney fibrosis in long-term ischemia-reperfusion injury.
Jiang S; Tang Q; Rong R; Tang L; Xu M; Lu J; Jia Y; Ooi Y; Hou J; Guo J; Yang B; Zhu T
Eur J Pharmacol; 2012 Aug; 688(1-3):56-61. PubMed ID: 22609232
[TBL] [Abstract][Full Text] [Related]
8. Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure.
Pechman KR; Basile DP; Lund H; Mattson DL
Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1234-9. PubMed ID: 18256138
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil inhibits regenerative repair in uranyl acetate-induced acute renal failure by reduced interstitial cellular response.
Sun DF; Fujigaki Y; Fujimoto T; Goto T; Yonemura K; Hishida A
Am J Pathol; 2002 Jul; 161(1):217-27. PubMed ID: 12107106
[TBL] [Abstract][Full Text] [Related]
10. Effects of mycophenolate mofetil on acute ischaemia-reperfusion injury in rats and its consequences in the long term.
Sabbatini M; Uccello F; Serio V; Troncone G; Varone V; Andreucci M; Faga T; Pisani A
Nephrol Dial Transplant; 2010 May; 25(5):1443-50. PubMed ID: 20031930
[TBL] [Abstract][Full Text] [Related]
11. Effect of mycophenolate mofetil on kallikrein expression in the kidney of 5/6 nephrectomized rats.
Ardiles LG; Ehrenfeld P; Quiroz Y; Rodriguez-Iturbe B; Herrera-Acosta J; Mezzano S; Figueroa CD
Kidney Blood Press Res; 2002; 25(5):289-95. PubMed ID: 12435874
[TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil improves renal haemodynamics, microvascular oxygenation, and inflammation in a rat model of supra-renal aortic clamping-mediated renal ischaemia reperfusion injury.
Ergin B; Heger M; Kandil A; Demirci-Tansel C; Ince C
Clin Exp Pharmacol Physiol; 2017 Feb; 44(2):294-304. PubMed ID: 27778375
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy.
Yang CW; Ahn HJ; Kim WY; Li C; Jung JY; Yoon SA; Kim YS; Cha JH; Kim J; Bang BK
Transplantation; 2003 Feb; 75(3):309-15. PubMed ID: 12589150
[TBL] [Abstract][Full Text] [Related]
14. Could mycophenolate mofetil combined with benazapril delay tubulointerstitial fibrosis in 5/6 nephrectomized rats?
Liu WH; Tang NN; Zhang QD
Chin Med J (Engl); 2009 Jan; 122(2):199-204. PubMed ID: 19187647
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil affects monocyte Toll-like receptor 4 signaling during mouse renal ischemia/reperfusion injury.
Zhang YX; Zhang JR; Wang ZG
Chin Med J (Engl); 2013 Apr; 126(7):1224-9. PubMed ID: 23557548
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil administration reduces renal inflammation, oxidative stress, and arterial pressure in rats with lead-induced hypertension.
Bravo Y; Quiroz Y; Ferrebuz A; Vaziri ND; Rodríguez-Iturbe B
Am J Physiol Renal Physiol; 2007 Aug; 293(2):F616-23. PubMed ID: 17567935
[TBL] [Abstract][Full Text] [Related]
17. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.
Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
Wu YG; Lin H; Qian H; Zhao M; Qi XM; Wu GZ; Lin ST
Inflamm Res; 2006 May; 55(5):192-9. PubMed ID: 16830106
[TBL] [Abstract][Full Text] [Related]
19. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney.
Fujihara CK; Malheiros DM; Zatz R; Noronha IL
Kidney Int; 1998 Nov; 54(5):1510-9. PubMed ID: 9844127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
